Evidence map›Paper›PMID 36364415›Full record

ArticleMolecules (Basel, Switzerland)2022

Green Extracellular Synthesis of Silver Nanoparticles by

Carlos Pernas-Pleite, Amparo M Conejo-Martínez, Irma Marín, José P Abad

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.1field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 19 citations in OpenAlex.

  1. TXRF Spectrometry for Investigating CaFInternational journal of molecular sciences · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. AgNPs biosynthesized fromFrontiers in microbiology · 2025
    Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Carlos Pernas-PleiteDepartment of Molecular Biology, Faculty of Sciences, Biology Building, Autonomous University of Madrid, Cantoblanco, 28049 Madrid, Spain.
Amparo M Conejo-MartínezDepartment of Molecular Biology, Faculty of Sciences, Biology Building, Autonomous University of Madrid, Cantoblanco, 28049 Madrid, Spain.
Irma MarínDepartment of Molecular Biology, Faculty of Sciences, Biology Building, Autonomous University of Madrid, Cantoblanco, 28049 Madrid, Spain.
José P AbadDepartment of Molecular Biology, Faculty of Sciences, Biology Building, Autonomous University of Madrid, Cantoblanco, 28049 Madrid, Spain.
Universidad Autónoma de Madrid · ES

Funding

Ministerio de Ciencia e Investigación PID2019-104812GB-100
6 · The paper itself

Abstract

Bacterial resistance to antibiotics is on the rise and hinders the fight against bacterial infections, which are expected to cause millions of deaths by 2050. New antibiotics are difficult to find, so alternatives are needed. One could be metal-based drugs, such as silver nanoparticles (AgNPs). In general, chemical methods for AgNPs' production are potentially toxic, and the physical ones expensive, while green approaches are not. In this paper, we present the green synthesis of AgNPs using two

Indexed as

Anti-Bacterial AgentsMetal NanoparticlesAmpicillinBacillus subtilisBiofilmsEscherichia coliMicrobial Sensitivity TestsPlant ExtractsPseudomonasPseudomonas aeruginosaSilverStaphylococcus aureusStreptomycinAmpicillinAnti-Bacterial AgentsPlant ExtractsSilverStreptomycinantibacterial activityantibioticsantimicrobial activitygreen synthesisnanoparticlesPseudomonas alloputidaROSsilversynergy

Identifiers

PMID36364415
PMCPMC9656067
OpenAlexW4308447255

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.